Avantor(US:AVTR) Globenewswireยท2025-11-11 13:25Core Viewpoint - A class action lawsuit has been filed against Avantor, Inc. for alleged violations of federal securities laws during the period from March 5, 2024, to October 28, 2025, seeking to recover losses for investors [1][3]. Company Performance - Avantor reported weaker-than-expected organic sales in its Laboratory Solutions segment on April 25, 2025, and reduced its 2025 outlook, with the CFO acknowledging increased competitive intensity leading to lower volumes at certain customers. This resulted in a stock price decline of over 16% [4]. - On August 1, 2025, Avantor announced disappointing second quarter results and further reduced its full-year guidance, indicating ongoing competitive pressures, which led to a stock price drop of more than 15% [5]. - On October 29, 2025, Avantor disclosed weak third quarter financial results, including a 5% decline in organic revenue, contradicting previous management assurances of an improving trajectory. Following this announcement, the stock price fell by more than 23% [6]. Allegations in the Lawsuit - The lawsuit alleges that Avantor and certain senior executives made false and misleading statements and failed to disclose the true state of the company's competitive position in key product lines, particularly in Laboratory Solutions, which was weaker than represented. It also claims that Avantor was negatively impacted by increased competition, adversely affecting volumes, sales, and growth [8].